This is a group of conditions where mast cells release too much of their chemicals. These chemicals cause various symptoms like rashes, breathing problems, and stomach issues. It can be caused by genetics, other diseases, or certain triggers like medications or foods.
Every report comes from a Lived member, sent anonymously.
Have you tried Zyrtec (Cetirizine) for Mast Cell Activation Disorders?
Mast cell activation disorders are conditions in which mast cells, immune cells that sit in the skin, gut, airways and around blood vessels, release their chemical signals too readily or are present in abnormal numbers. Those signals, called mediators, include histamine and act within minutes. The result is episodes that resemble an allergic reaction: flushing, hives or itching, abdominal cramps and diarrhea, a racing heart, and lightheadedness or fainting when blood pressure drops. The most severe episodes are anaphylaxis, a life-threatening reaction affecting several body systems at once. The term is an umbrella. Mastocytosis means the body makes too many abnormal mast cells: in children it usually affects only the skin, while in adults it is more often systemic, involving the bone marrow and sometimes other organs. Mast cell activation syndrome (MCAS) describes severe, recurrent episodes of mast cell activation that can be confirmed with testing. It can occur with mastocytosis, with an allergy or with no cause found. Many symptoms that suggest mast cell activation also have other explanations, so the label needs careful confirmation rather than being assumed.
Clinicians sort MCAS by what lies behind it. In primary MCAS, mast cells carry a change in a gene called KIT that keeps them switched on; this is the same change found in most adults with systemic mastocytosis, and it is acquired during life rather than inherited. In secondary MCAS, a different condition drives the episodes, most often a true allergy involving IgE (the antibody behind classic allergic reactions). In idiopathic MCAS, no clonal mast cells, allergy or other explanation is found. Some people have more than one factor at once, and the combination of mastocytosis with an insect venom allergy carries the highest risk of severe reactions. Hereditary alpha-tryptasemia is a related, inherited trait in which extra copies of a gene raise blood levels of tryptase, a mast cell enzyme. It runs in families and can be associated with mast cell symptoms, though many people with it have none. Triggers set off episodes but do not cause the underlying disorder. Commonly reported ones include sudden temperature changes, friction or pressure on the skin, insect stings, alcohol, infections, physical or emotional stress, surgery, and certain medicines such as aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs), opioid pain medicines and some drugs used during anesthesia. Triggers vary from person to person, and some episodes have no identifiable trigger.
There is no single test. Under the widely used international consensus criteria, MCAS is diagnosed when three things are all present: typical severe episodes involving more than one body system, a laboratory sign that mast cells released their mediators during an episode, and improvement with medicines aimed at mast cells or their mediators. The key laboratory test is serum tryptase. Timing matters: a blood sample is best taken 1 to 4 hours after an episode begins and compared with a baseline level drawn at least a day or two after the person has fully recovered. A rise of more than 20% above baseline plus 2 ng/mL supports the diagnosis. For example, if someone's baseline is 5 ng/mL, a level above 8 ng/mL during an episode would count. When tryptase cannot be captured, urine tests for breakdown products of histamine and of two other mast cell mediators, prostaglandins and leukotrienes, can add evidence, though they are less specific to mast cells. A high baseline tryptase on its own does not mean MCAS. A level that stays above 20 ng/mL prompts testing for systemic mastocytosis or hereditary alpha-tryptasemia, which may include a sensitive blood test for the KIT gene change, a bone marrow biopsy and genetic testing. An allergy evaluation looks for triggers such as foods, medicines or insect venom. An equally important part of the workup is ruling out other conditions that cause flushing, diarrhea, fainting or fast heart rate, including heart, hormonal, gastrointestinal and neurological problems. Specialists report that many people referred with suspected MCAS turn out to have a different explanation. Some clinicians use broader diagnostic criteria than the consensus definition, so two specialists can reach different conclusions about the same symptoms; asking which criteria were used can help make sense of a diagnosis.
Treatment aims to reduce day-to-day symptoms and prevent severe reactions. It usually starts with identifying and avoiding personal triggers, then adds medicines in steps until symptoms are controlled. Most plans begin with antihistamines that block two different histamine receptors, known as H1 and H2: H1 blockers such as cetirizine or fexofenadine, which mainly help itching, hives and flushing, and H2 blockers such as famotidine, which mainly help stomach and gut symptoms. Other options target different mediators: montelukast (Singulair), a leukotriene blocker; oral cromolyn, which helps keep mast cells from releasing their contents and can ease diarrhea, abdominal pain and flushing in some people with mastocytosis; and, under specialist supervision, aspirin for flushing driven by prostaglandins, which must be started carefully because aspirin itself can trigger reactions in some people. Omalizumab (Xolair), an injected antibody that blocks IgE, is sometimes used off-label when episodes persist. Corticosteroids may be used for short periods to settle prolonged flares. Finding the right combination often takes several adjustments, and responses differ between people. Anyone who has had anaphylaxis is usually prescribed epinephrine auto-injectors and taught when to use them. People with clonal mast cell disease and an insect venom allergy are typically advised to continue venom immunotherapy (allergy shots) long term, because protection appears to last only while treatment continues. Systemic mastocytosis can also be treated at its source. Avapritinib (Ayvakit), a daily tablet that blocks the overactive KIT protein driving the abnormal mast cells, is FDA approved for adults with indolent (slow-growing) or advanced systemic mastocytosis. Its main trade-offs are a risk of bleeding in the brain, seen mainly in people treated for advanced disease, and possible effects on memory and thinking, so it is not used when platelet counts are very low and treatment involves regular monitoring. Advanced forms are managed by a hematologist, sometimes with other targeted drugs or chemotherapy.
The course depends on which disorder is present. MCAS is usually long-term, with symptoms that wax and wane. Many people reach good day-to-day control once a regimen and their triggers are worked out, though this can take months of adjustment. Keeping a record of episodes, suspected triggers and how medicines help gives the care team better information than memory alone. Most adults with systemic mastocytosis have the indolent form and a normal or near-normal life expectancy, though symptoms can still affect daily life. The less common advanced forms can damage the liver, spleen, bone marrow or bones, shorten survival and need ongoing specialist treatment. Planning ahead makes medical care safer. Surgery, anesthesia, other procedures and new medicines can provoke episodes, so it helps to tell every clinician about the diagnosis in advance; anesthesia teams can choose drugs and give preventive medicines. Carrying epinephrine, when prescribed, and wearing medical identification are common parts of daily life. Follow-up typically involves an allergist or immunologist, with a hematologist added for systemic mastocytosis.
Arrange an evaluation if you have recurring episodes of flushing, hives, abdominal cramps, diarrhea or near-fainting that affect more than one part of the body, or if a known mast cell disorder is no longer controlled by your current treatment. Contact your care team soon after any significant episode, ideally while a tryptase level can still be drawn within about 4 hours, and before any planned surgery, procedure or new medicine. Signs of anaphylaxis need emergency care: trouble breathing or wheezing, tightness in the throat or swelling of the lips or tongue, or fainting, a weak pulse or collapse. Use an epinephrine auto-injector right away if you have one, and call 911.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Mast Cell Activation Disorders is like, what's helped you, or ask the community a question.